Table 2.
Parameters | Control | DM + CL | DM‐Con |
---|---|---|---|
BW (g) | 29.91 ± 0.97 | 30.51 ± 0.55 | 29.24 ± 0.70 |
KW (g) | 0.20 ± 0.02 | 0.22 ± 0.01† | 0.27 ± 0.02** |
KW/BW (×10−3) | 6.40 ± 0.42 | 6.94 ± 0.37†† | 9.03 ± 0.49** |
RBG (mM)2 | 8.30 ± 0.46 | 20.58 ± 3.55* | 23.6 ± 3.87** |
Food intake (kcal/day per mouse) | 11.82 ± 0.31 | 18.92 ± 0.80*** , †† | 15.72 ± 0.50** |
Serum Cr (μM) | 22.79 ± 6.79 | 23.4 ± 5.43 | 24.65 ± 5.25 |
Urine volume (mL) | 1.84 ± 0.22 | 2.77 ± 1.20† | 11.50 ± 2.09* |
Data are the mean ± SEM (n = 7–9 per group).
BW, body weight; Cr, creatinine; DM + CL, diabetic mice treated with CL316,243; KW, kidney weight; RBG, random blood glucose.
P < 0.05
P < 0.01
P < 0.001 compared with the control (normal) group
P < 0.05;
P < 0.01 compared with the diabetic control (DM‐Con) group.